Patent · US Active

Human plasma kallikrein inhibitors

US11708332B2 · kind B2 · utility

2Cited by
11References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2021
Grant dateJul 25, 2023
Priority date—
Expiry dateNov 15, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.